OFI Italian Pharmaceutical

Bergamo, Italy Founded: 1946 • Age: 80 yrs Acquired By Alto Partners
Pharmaceutical products are manufactured by OFI Italian Pharmaceutical in Italy.

About OFI Italian Pharmaceutical

OFI Italian Pharmaceutical is a Healthcare company based in Bergamo (Italy) founded in 1946, and was acquired by Alto Partners in April 2019. Pharmaceutical products are manufactured by OFI Italian Pharmaceutical in Italy. OFI Italian Pharmaceutical offers products and services including Dietary Supplements and Medical Devices. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity in India is Ofi (India) Private Limited (U74140DL2013PTC251554).

Company details

OFI Italian Pharmaceutical was established in 1946 in Bergamo, Italy, within the pharmaceutical sector. Manufacturing operations are centered on producing medicinal products for healthcare applications. The companys activities are conducted from its Italian base, with an online presence maintained through the domain ofi.it. Focus remains on standard pharmaceutical production processes, supporting regional and potential international distribution needs.

  • Headquarters Bergamo, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ofi.it
  • Social LinkedIn
  • Acquired by Alto Partners (Apr 2019)
  • Legal Name Ofi (India) Private Limited
  • Date of Incorporation 03 May, 2013
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Indian entity revenue
    ₹87,691

    FY 2023

  • Indian entity net profit
    ₹87,232

    FY 2023 · 99% margin

  • Indian entity EBITDA
    ₹87,560

    FY 2023 · 100% margin

  • Investors
  • Acquired by
    Alto Partners

    (Apr 2019)

Products & Services of OFI Italian Pharmaceutical

OFI Italian Pharmaceutical offers a comprehensive portfolio of products and services, including Dietary Supplements and Medical Devices.

Dietary Supplements
Health Products

Dietary supplements are developed and manufactured by Officina Farmaceutica Italiana for third parties, ensuring nutritional conformity and quality in formulations

Medical Devices
Healthcare Products

Medical devices are produced by Officina Farmaceutica Italiana through controlled processes to guarantee product efficacy and safety

Funding Insights of OFI Italian Pharmaceutical

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of OFI Italian Pharmaceutical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2010Private Equity Round––
Valuation history

2 investors in total: 2 institutional.

Investors in OFI Italian Pharmaceutical

OFI Italian Pharmaceutical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Futurimpresa and Alto Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
futurimpresa.it
altopartners.it
Premium access

Investor details for OFI Italian Pharmaceutical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Ofi (India) Private Limited (OFI Italian Pharmaceutical)

Ofi (India) Private Limited is the primary company behind OFI Italian Pharmaceutical. The board of Ofi (India) Private Limited currently have 4 directors; the longest-serving is Sanjiv Khurana, appointed in 2013. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sanjiv Khurana
DIN 00524231
Director03 May 201313 yrs 6 moOfi (India) Private Limited
Arjun Khurana
DIN 00524276
Managing Director03 May 201313 yrs 6 moOfi (India) Private Limited
Roberto Rettani
DIN 06530294
Director13 Nov 201313 yrsOfi (India) Private Limited
Alberto Donati
DIN 06524642
Director13 Nov 201313 yrsOfi (India) Private Limited

Financials of OFI Italian Pharmaceutical

Figures of Ofi (India) Private Limited, the primary company behind OFI Italian Pharmaceutical, for FY 2023. Revenue was ₹87,691. Net profit was ₹87,232 (99% margin). EBITDA was ₹87,560 (100% margin). Revenue has grown at a compounded annual rate of -40% over three years and -58% over five years.

  • ₹87,691Revenue · FY 2023
  • ₹87,232Net profit · 99% margin
  • ₹87,560EBITDA · 100% margin
  • ₹4.80 CrPaid-up capital
  • -40%Revenue CAGR, 3 years
  • -58%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ofi (India) Private Limited are on its company page.

Premium access

Detailed financial statements for OFI Italian Pharmaceutical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of OFI Italian Pharmaceutical

3 dated milestones of OFI Italian Pharmaceutical across 73 years, from founding to its latest funding, stage changes and deals.

  1. Founded OFI Italian Pharmaceutical is founded.
  2. Funding First funding round.
  3. Exit Acquired by Alto Partners.

Web traffic of OFI Italian Pharmaceutical

The website of OFI Italian Pharmaceutical (ofi.it) receives about 2.5K visits a month and ranks #9,486,814 among all websites worldwide, #7,688 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    2.5K

    ▲ 49.2% vs previous month

  • Global rank
    #9,486,814

    among all websites

  • Category rank
    #7,688

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with OFI Italian Pharmaceutical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ibi-lorenzini.it
100%
5.4K#2,714,888View details
fidiapharma.it
fidiapharma.it
93%
#2,360,346–
e-pharma.com
e-pharma.com
92%
#10,389,578–
lfm.it
lfm.it
92%
#4,023,486–
biofarmagroup.com
83%
15.7K#1,639,133View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 16 similar websites and full traffic analytics for OFI Italian Pharmaceutical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about OFI Italian Pharmaceutical

OFI Italian Pharmaceutical was founded in 1946 and raised its 1st funding round 64 years after it was founded.

OFI Italian Pharmaceutical is headquartered in Bergamo, Italy. It is registered at Bergamo, Lombardy, Italy.

The primary company behind OFI Italian Pharmaceutical, Ofi (India) Private Limited, reported revenue of β‚Ή87,691 for FY 2023.

OFI Italian Pharmaceutical was established in 1946 in Bergamo, Italy, within the pharmaceutical sector. Manufacturing operations are centered on producing medicinal products for healthcare applications. The companys activities are conducted from its Italian base, with an online presence maintained through the domain ofi.it. Focus remains on standard pharmaceutical production processes, supporting regional and potential international distribution needs.

OFI Italian Pharmaceutical offers Dietary Supplements and Medical Devices.

OFI Italian Pharmaceutical has 2 investors. Key investors include Futurimpresa, and Alto Partners.

OFI Italian Pharmaceutical operates through Ofi (India) Private Limited.

Yes. OFI Italian Pharmaceutical was acquired by Alto Partners in April 2019.

The legal entities of OFI Italian Pharmaceutical currently have 4 directors, including Sanjiv Khurana, Arjun Khurana, Roberto Rettani and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available